Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of solid tumor indications, announced that it has...
Orexo AB, continues to develop its innovative powder-based drug delivery technology AmorphOX to improve the properties of new or existing drugs. The aim is to...
NeoPhore Limited, a small molecule neoantigen immuno-oncology company, announces the appointment of Michael Shih as Chief Executive Officer (CEO) and to the Board of Directors, effective...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Parse Biosciences, the leader in scalable single-cell sequencing solutions, announced the expansion of its Evercode BCR product line to support applications in mice. The...
